Evidence map›Paper›PMID 27422115›Full record

ArticleCancer immunology, immunotherapy : CII2016

Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice.

Abderraouf Selmi, Fulvia Vascotto, Kordula Kautz-Neu, Özlem Türeci, Ugur Sahin, Esther von Stebut, Mustafa Diken, Sebastian Kreiter

Abstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Circular RNA vaccine in disease prevention and treatment.Signal transduction and targeted therapy · 2023
    Review
  13. mRNA: A promising platform for cancer immunotherapy.Advanced drug delivery reviews · 2023
    Review
  14. Advanced delivery systems for peptide antibiotics.Advanced drug delivery reviews · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Theranostics · 2023
    Article
  19. The Delivery of mRNA Vaccines for Therapeutics.Life (Basel, Switzerland) · 2022
    Review
  20. mRNA vaccines for COVID-19 and diverse diseases.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abderraouf SelmiTRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany.
Fulvia VascottoTRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany.
Kordula Kautz-NeuDepartment of Dermatology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
Özlem TüreciCluster for Individualized Immune Intervention (CI3), Mainz, Germany.
Ugur SahinTRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany.
Esther von StebutDepartment of Dermatology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
Mustafa DikenTRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany. Mustafa.Diken@TrOn-Mainz.de.
Sebastian KreiterTRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131, Mainz, Germany. Sebastian.Kreiter@TrOn-Mainz.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intradermal administration of antigen-encoding RNA has entered clinical testing for cancer vaccination. However, insight into the underlying mechanism of RNA uptake, translation and antigen presentation is still limited. Utilizing pharmacologically optimized naked RNA, the dose-response kinetics revealed a rise in reporter signal with increasing RNA amounts and a prolonged RNA translation of reporter protein up to 30 days after intradermal injection. Dendritic cells (DCs) in the dermis were shown to engulf RNA, and the signal arising from the reporter RNA was significantly diminished after DC depletion. Macropinocytosis was relevant for intradermal RNA uptake and translation in vitro and in vivo. By combining intradermal RNA vaccination and inhibition of macropinocytosis, we show that effective priming of antigen-specific CD8(+) T-cells also relies on this uptake mechanism. This report demonstrates that direct antigen translation by dermal DCs after intradermal naked RNA vaccination is relevant for efficient priming of antigen-specific T-cells.

Indexed as

AnimalsCD8-Positive T-LymphocytesDendritic CellsFemaleHumansInjections, IntradermalMiceMice, Inbred C57BLPinocytosisRNARNACancer immunotherapyDermal dendritic cellIntradermal vaccinationMacropinocytosisNaked RNARNA vaccine

Identifiers

PMID27422115
PMCPMC11028682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.